NHS Medical Cannabis Guide UK 2026 – Eligibility, Prescriptions & RSO Access
On this page:
This page summarises official NHS guidance on medical cannabis in the UK (as of July 2026). For the most accurate information always refer to NHS.uk.
Traditional RSO and most high-THC oils are not routinely prescribed on the NHS.
Most patients access RSO-style products privately through specialist clinics (prices often start from £30+ per gram).
Fresh July 2026 batch shown – dated for clarity (licensed contexts only).
When Is Medical Cannabis Prescribed on the NHS? (2026)
- Severe treatment-resistant epilepsy (Epidyolex)
- Chemotherapy nausea and vomiting (Nabilone)
- MS-related muscle spasticity (Sativex)
NHS-Approved Medical Cannabis Products (2026)
| Product | Main Condition | Type | NHS Availability |
|---|---|---|---|
| Epidyolex | Severe epilepsy | Pure CBD | Yes (specialist only) |
| Sativex | MS spasticity | THC/CBD spray | Limited |
| Nabilone | Chemotherapy nausea | Synthetic THC | Yes (specialist) |
Private RSO Access – Most Common Route in 2026
Because NHS access is extremely limited, most people seeking RSO oil go through private specialist clinics. Many clinics can prescribe high-THC oils similar to RSO from licensed suppliers, often starting from £30 per gram.
Practical Steps to Access RSO Privately
- Discuss symptoms with your GP or self-refer to a specialist clinic
- Attend assessment with GMC-registered specialist (£150–£300)
- If approved, receive prescription for RSO-style product
- Obtain medication from licensed supplier with tracked delivery
Looking for Private RSO Options?
Important Legal & Medical Disclaimer
This page is for educational purposes only. Medical cannabis is a controlled substance. NHS access is very limited. Always consult a qualified doctor and official sources (NHS, MHRA, GMC). This website does not sell or supply cannabis products.